Unlock instant, AI-driven research and patent intelligence for your innovation.
Bacillus tubercle gene vaccine for treating medicine-tolerant pulmonary tuberculosis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of Mycobacterium tuberculosis and genetic vaccines, applied in the direction of antibacterial drugs, bacterial antigen components, etc.
Inactive Publication Date: 2012-05-23
中国人民解放军总医院第二附属医院 +1
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
These three vaccines are dead vaccines, which can only induce humoral immunity and Th1-type cellular immune responses, but cannot induce specific cytotoxic T lymphocyte (CTL) responses
[0006] At present, there are no research reports on the application of nucleic acid vaccines in the treatment of drug-resistant tuberculosis at home and abroad
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0130] It is used to prepare the Mycobacterium tuberculosis gene vaccine for treating drug-resistant tuberculosis, one of which is that the Mycobacterium tuberculosis Ag85A coding gene sequence is cloned into the eukaryotic expression vector pVAX1.
[0189]The tuberculosis gene vaccine used for preparing drug-resistant tuberculosis is cloned into the eukaryotic expression vector pVAX1 to form the ESAT6-Ag85A chimeric gene vaccine.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
technical field [0001] The invention relates to the preparation of tubercle bacillus gene vaccine for treating drug-resistant tuberculosis. Background technique [0002] So far, tuberculosis is still the number one "killer" of infectious diseases in the world. The main reason is that BCG vaccine cannot effectively prevent tuberculosis in adults. start to pick up. The World Health Organization (WHO) reports that there are currently 20 million tuberculosis patients in the world, 8-10 million new tuberculosis patients are added every year, and 2-3 million people die of tuberculosis every year. The tuberculosis epidemic and drug resistance in my country are quite serious, and the number of tuberculosis patients ranks second in the world, second only to India. The results of the fourth national tuberculosis epidemiological sampling survey in 2000 showed that 550 million people in my country were infected with tuberculosis, and there were 4.51 million tuberculosis patients, with...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.